The inhibitor of apoptosis wild-type survivin is a multifunctional protein that suppresses apoptosis and regulates cell cycle progression. An association between wild-type survivin expression and radiosensitivity has been described in different tumor cells. The effects of siRNA-induced knockdown of wild-type survivin and survivin-splice variants survivin-2B and survivin-D3 were investigated under normoxic and hypoxic conditions in the human sarcoma cell line US 8-93 (mutant p53). Inhibition of the survivin isoforms by siRNA resulted in a decrease of target mRNA down to 14-70% compared to cells treated with control siRNA independent of the oxygen level. The mRNA expression of survivin isoforms was decreased by the factor of 1-12 when the cells were cultivated under hypoxic conditions. Moreover, the knockdown of wild-type survivin reduced colony formation independent of oxygen concentration down to 70% and induced formation of polyploid cells. Less reduction of plating efficiency was observed after specific knockdown of survivin-2B and survivin-D3 under hypoxic or normoxic conditions. A knockdown of wild-type survivin, survivin-D3 and survivin-2B isoforms in combination with irradiation caused no radiosensitization in cell line US 8-93, neither under hypoxic nor under normoxic conditions tested in the colony-forming assay. However, knockdown of wild-type survivin caused radiosensitization in the megacolony assay.
Introduction
A promising tumor target gene for improving the therapeutic potential of anticancer drugs is the inhibitor of apoptosis survivin. 1 It is overexpressed in most types of cancer cells and embryonic tissue, but little is detected in terminally differentiated normal tissue. 2 Overexpression of survivin was correlated with a poor prognosis in different carcinomas, lymphomas and leukemias. 2 In soft tissue sarcoma, overexpression of survivin mRNA or survivin protein is significantly correlated with a higher risk of tumor-related death. 3, 4 Survivin is a multifunctional protein that suppresses apoptosis and regulates cell cycle progression. [5] [6] [7] [8] [9] [10] Furthermore, human survivin is negatively regulated by wild-type p53. [11] [12] [13] [14] In a previous study, in five soft tissue sarcoma cell lines a reduced plating efficiency and occurrence of polyploidy independent of the p53 gene status was observed after treatment with survivin-specific siRNA. 15 This finding is in accordance with results of survivin knockdown experiments in other cancer cell lines. 5, [16] [17] [18] [19] [20] Furthermore, survivin overexpression was associated with radioresistance in tumor cell lines. [21] [22] [23] [24] [25] [26] The knockdown of survivin by ribozymes resulted in an increase of sensitivity of mt-p53 melanoma cells to irradiation. 22 Moreover, transfection of survivin made radiosensitive pancreatic cancer cells more radioresistant and inhibited the activity of caspase-3. 27 The knockdown of survivin by siRNA increased apoptosis and caspases-3/-7 activity in colorectal cancer cells. This was associated with decreased clonogenic survival. 24 We found that suppression of survivin resulted in a significant radiosensitization and in an increase in activity of caspases-3/-7 in cell line A-204 (wt-p53), but not in the cell line US 8-93 (mt-p53). 28 Little is known about the splice variants of survivin. The survivin gene has four dominant (1, 2, 3 and 4) and three hidden (2B, 2a and 3B) exons. 29 Alternative splicing of its pre-mRNA results in five different mRNAs: wild-type survivin, survivin-2B, survivin-D3, 30 survivin-2a 31 and survivin-3B. 32 Survivin (142 aa) is derived from exons 1-4; survivin-2B (167 aa) has 23 amino acids in addition to survivin protein derived from a 69-bp cryptic exon (2B) within intron 2, which is spliced in-frame between exons 2 and 3; survivin-D3 (137 aa) is derived from exons 1, 2 and 4, a frameshift read-through variant due to exon 3 escape. 33 It has been suggested that survivin-D3 has antiapoptotic activity similar to survivin, whereas survivin-2B might have a pro-apoptotic function. 30, 34 A model proposed that survivin-2B or survivin-D3 may heterodimerize with survivin to modulate the role of survivin in control of mitosis and/or apoptosis and change the normal localization of the survivin isoforms. 33, 34 Recently, an inhibitory function of survivin and survivin-D3 for mitochondrial-dependent apoptosis was determined. 35 Noton et al. 36 demonstrated that neither survivin-2B nor survivin-D3 has an essential function during mitosis or can rescue cell growth restrictions caused by wild-type survivin depletion. The function of the different survivin isoforms in the context of the anti-apoptotic activities of wild-type survivin remains to be elucidated. 36 The survivin isoforms have an impact on treatment outcome of patients. Patients with soft tissue sarcoma whose tumors overexpressed survivin-D3 had a sevenfold increased risk of tumor-related death. 37 Recently, it has been found that tumor-specific expression of survivin is increased by hypoxia, and the addition of hypoxia-responsive elements to the survivin promoter results in a further increase in its expression. 38 It seems that survivin expression is dependent and independent of the most prominent factors of hypoxia and angiogenesis Hif-1a and VEGF, respectively. 6, 39 Our studies suggest that survivin expression is linked with hypoxia and prognosis in advanced cervical cancers. 40 To investigate the importance of survivin variants, we applied siRNA against wild-type survivin, survivin-2B or survivin-D3 under normoxic or hypoxic conditions in a soft tissue sarcoma cell line.
Materials and methods

Cell culture conditions
The sarcoma cell line with mutant-p53 US 8-93 was established in the Institute of Pathology in Halle (S), Germany. 41 Cells were maintained in the logarithmic growth phase at 37 1C in a humidified atmosphere supplemented with 3% CO 2 . The cell line was grown as monolayer in RPMI-1640 (PAA, Co¨lbe, Germany) with 10% fetal bovine serum (FBS, PAA), 1% sodium pyruvate, 185 U ml À1 penicillin and 185 mg ml À1 streptomycin. Cells were trypsinized and passaged every 2-3 days.
Transfection
For siRNA experiments, a defined number of cells (1.5-6 Â 10 5 ) were incubated in 12.5-cm 2 flasks 24 h before transfection; the confluence of the cell monolayer at the time of transfection was 40-60%. Cells were cultured in serum-free medium OptiMEM (Invitrogen, Karlsruhe, Germany) for 4 h before the start of transfection. The survivin-specific siRNAs (MWG, Ebersberg, Germany) or nonsense siRNA (each 200 nM) were mixed with Oligofectamin (Invitrogen) transfection agent according to the manufacturer's instructions. After transfection at 37 1C for 6 h, the transfection solution was replaced by RPMI-1640 medium.
Sequences of applied siRNAs that correspond to mRNA sequences from the NCBI database: wild-type survivin (NM_001168), survivin-D3 (NM_001012270) and survivin-2B (NM_001012271) are shown. Lu GL2-siR-NA; all siRNA were synthesized by MWG. The scheme of binding sites of siRNA are shown in Figure 1 .
Irradiation and hypoxia
After siRNA transfection, the flask with treated cells was transferred into gas-proof plastic bags (Anaerocult P; Merck, Darmstadt, Germany). After absorption of oxygen inside the bag via a chemical agent, cells were cultivated for 24 h under hypoxic conditions (o1% oxygen). The hypoxic conditions were monitored by a At 48 h after siRNA treatment and 24 h under hypoxia, cells were irradiated at room temperature with a single dose of 0-14 Gy under hypoxic conditions. The cells, which were cultivated under normoxic conditions, were transfected, cultivated for 24 h, plated and irradiated after 24 h. A Phillips RT 250 was used filtered with 0.5 Cu. At a distance of 40 cm, the dose rate was 2 Gy min
À1
. The cells were harvested within 3 h after irradiation for further analysis (mRNA expression, protein expression or cell cycle analyses).
RNA preparation, cDNA synthesis and quantitative fluorescence reverse transcription (RT)-PCR Cells, which were used for RNA or protein isolation, were harvested 3 h after irradiation. RNA was isolated by using the RNeasy Mini Kit according to the manufacturer's instructions (QIAGEN, Hilden, Germany). RNA samples were stored at À80 1C.
For cDNA synthesis, the template (1 mg RNA per sample) was mixed with 160 U Superscript T II RNaseH reverse transcriptase, 10 mM dNTP mix, 4 ml buffer, 10 mM dithiothreitol and 250 ng random hexameric primers (Invitrogen). Reverse transcription was carried out for 75 min at 42 1C.
All three survivin transcript variants (each separately) and 18S RNA transcript were measured from cDNA in duplicate experiments by ready-to-use PCR assays (AJ Roboscreen GmbH, Leipzig, Germany).
Protein extraction and western blot hybridization
Transfected cells were washed, trypsinated and centrifuged. The supernatant of cells was washed with PBS and resuspended in 100 ml lysis buffer (50 mM Tris, pH 8.0, 0.3 M NaCl, 1 mM EDTA, 0.5 mM dithiothreitol, 0.1% NP40, protease inhibitors solution dilution). The lysis was accomplished by three heating cycles at 37 1C and freezing at À80 1C. After centrifugation at 14 000 g for 15 min, the supernatant was collected and the protein concentration was determined using the Bradford assay (BioRad, Mu¨nchen, Germany).
About 30 mg of total protein from each cell lysate was separated on a 10% NuPAGE Bis-Tris (Invitrogen) gel that was placed in an X-Cell SureLock Mini-Cell (Invitrogen). After protein transfer the membranes were incubated in blocking buffer (3% skimmed milk powder, TBS, 0.1% Tween-20) for 1 h, and then incubated with rabbit anti-human survivin antibody (dilution 1:1000, clone AF886; R&D Systems, Wiesbaden, Germany) overnight at 4 1C. After washing, the membranes were incubated with a horseradish peroxidase-labeled goat anti-rabbit IgG (1:2000 dilution; DAKO, Glostrup, Denmark) for 1 h at room temperature. For protein detection, membranes were incubated with ECL substrate for 1 min (Amersham Pharmacia Biotech, Freiburg, Germany) and exposed to X-ray film (Biomax; Kodak, Braunschweig, Germany). For internal control, blots were re-hybridized with b-actin (mouse anti-human b-actin antibody-Ac15; 1:1000 dilution; Sigma, St Louis, MO) and then further treated as described above.
Clonogenic survival assay and radiosensitivity At 24 h after transfection and immediately after irradiation, the hypoxic cells were harvested by trypsination. Depending on the optimal plating efficiency for each sarcoma cell line, about 300-8000 cells were seeded in 25-cm 2 flasks in a dose-dependent manner (with increasing numbers of cells at higher dose) and cultivated at 37 1C.
The medium was changed after 5 days. Between 10 and 14 days after siRNA transfection, the medium was discarded and the cells were stained with Giemsa (Sigma). The number of colonies that contained more than 20 cells was counted to determine the surviving fraction, determined as the ratio of number of colonies formed by irradiated cells to number of colonies formed by non-irradiated cells. The enhancement factor was determined as the ratio of survival fraction of survivin-specific siRNA-treated cells to luciferase siRNA-treated control cells. The data represent at least three independent experiments.
Cell cycle analyses
Transfected cells were analyzed for cell cycle distribution. About 5 Â 10 5 cells were harvested and washed in PBS. Subsequently, 95% ethanol was added slowly until a final concentration of 80% was reached. The DNA content, which was indicated by the extent of staining of propidium iodide, was measured by flow cytometry in an FACSscan (Becton Dickinson, Heidelberg, Germany), using the CellFit software (Version 2.0).
Megacolony assay
For the megacolony assay, 5 Â 10 4 cells (per spot) of siRNA-treated cells were seeded into 50-cm 2 flasks. 42 Six to eight spots per flask were seeded 24 h after transfection with siRNA against wild-type survivin or luciferase. At 24 h after seeding, the growing cells were washed with PBS and incubated with fresh complete medium. Four hours later, the cells were irradiated with a dose between 10 and 27 Gy. The medium was changed after 7 days. Between 14 and 21 days after siRNA transfection, cells were washed with PBS, fixed with formalin for 10 min and stained with hemalum (Merck). The megacolony was classified as cured, when the megacolony had disappeared and no recurrent colony could be observed. The D 50 is the radiation dose that characterizes a survival fraction of 50% of the megacolonies. The data represent the results of at least three independent experiments.
Statistical analysis
The experimental results of the clonogenic survival assay were analyzed with the two-sided paired Student's t-test. A P-valueo0.05 was considered as significant.
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Results
Survivin-splice variant expression under hypoxic or normoxic conditions and effects of siRNA constructs on RNA and protein expression The expression of survivin isoforms mRNA strongly differed between hypoxic and normoxic conditions. Expression of wild-type survivin and survivin-2B was one-to threefold less and the expression of survivin-D3 was 4-to 12-fold less under hypoxic conditions than under normoxic conditions in the cell line US 8-93, respectively (Table 1 ). All siRNA constructs against survivin isoforms effectively knocked down their specific target mRNA under normoxic conditions as well as under hypoxic conditions ( Table 2 ). The siRNA construct SVV 284 decreased wildtype survivin and survivin-2B below 39% compared to the cells treated with siRNA luciferase. The siRNA constructs D3 or siRNA 2B decreased their specific target mRNA survivin-D3 or survivin-2B below 70 or 56% compared to the cells treated with control siRNA, respectively ( Table 2 ). The relative inhibition of wild-type survivin or survivin-2B expression caused by siRNA application is with the exception of survivin-D3 expression similar between normoxic and hypoxic conditions ( Table 2) .
The reduction of wild-type survivin protein demonstrated the effectiveness of knocking down of survivin via siRNA 284 (Figure 2 ). The application of siRNA constructs D3 or siRNA 2B had no effect on wild-type survivin expression detected in the western blot hybridization (Figure 2 ). The polyclonal antibodies applied against survivin-2B or survivin-D3 were not specific (data not shown).
Effects of survivin-specific siRNA on clonogenic survival and cell cycle distribution in the human sarcoma cell line under different oxygen conditions Only the siRNA construct SVV 284 against survivin reduced the plating efficiency below 30% under hypoxic and normoxic conditions (Figure 3 ), whereas the siRNA constructs D3 or 2B did not decrease the plating efficiency below 70% compared to cells treated with luciferase control siRNA, respectively, independent of the oxygen status ( Figure 3) . By using SVV 284 siRNA against survivin, an increased accumulation of cells in the G 2 /M phase 24 h after transfection and the formation of polyploid cells was found. At 24 and 48 h after transfection of cell line US 8-93, almost 40 and 50% of the cells treated with SVV 284 siRNA were polyploid, respectively (data not shown). In contrast, the application of siRNA directed against survivin-2B, survivin-D3 or luciferase control did not Abbreviations: RT-PCR, real time PCR; siRNA, small interfering RNA.
Underlined results correspond to mRNA isoform, which was primarily targeted by the specific siRNA. Cells were cultivated under normoxic or hypoxic conditions. Furthermore, the ratio normoxic/hypoxic mRNA expression of survivin isoforms was calculated. Note that siRNA 284 reduced not only survivin but as expected also the splice variant survivin-2B. The data represent the mean value of at least three independent experiments. Results of quantitative RT-PCR for survivin isoforms demonstrated a specific reduction of the target mRNA after specific siRNA treatment (underlined results correspond to mRNA isoform, which was primarily targeted by the specific siRNA). Results were compared to luciferase siRNA reference for cells treated under normoxic or hypoxic conditions. Note that siRNA SVV 284 reduced not only wildtype survivin but as expected also the splice variant survivin-2B.
Effects of knockdown of wild-type survivin, survivin-2B or survivin-D3 M Kappler et al affect cell cycle distribution, and no polyploid cells were generated (data not shown).
Effect of survivin knockdown on the radiosensitivity measured of soft tissue sarcoma cell line The combination of siRNA treatment and irradiation clearly indicated that the cell line US 8-93 (mt-p53) is relatively radioresistant with a width of the shoulder (n ¼ 4) and a D 50 of about 6 Gy under normoxic conditions ( Figure 5 ). Despite the effectiveness of the specific siRNAs to inhibit survivin isoforms expression, no radiosensitization for the cell line US 8-93 (mt-p53) was found, neither under hypoxic conditions nor under normoxic conditions (Table 3 ; Figures 4 and 5) . 
Discussion
Tumor hypoxia has an impact on treatment outcome of soft tissue sarcoma patients treated with radiotherapy. 43, 44 Nordsmark et al. 43 found that hypoxia, measured via Effects of knockdown of wild-type survivin, survivin-2B or survivin-D3 M Kappler et al polarographic oxygen-sensitive electrodes, was an indicator for a poorer disease-specific survival (P ¼ 0.05) as well as overall survival (P ¼ 0.01) for soft tissue sarcoma patients. The overexpression of the major molecular marker of hypoxia, the hypoxia-inducible factor (Hif1a), also correlated with a shorter overall survival rate in a multivariate analysis (P ¼ 0.018). 44 For understanding the effect of hypoxia in vivo, we analyzed the expression of survivin in vitro to investigate the impact of survivin variants in response to irradiation under different oxygen concentrations.
Survivin, a member of the inhibitor of apoptosis family, could be a link between radioresistance and hypoxia. In a previous study, we showed that irradiation and a survivinspecific knockdown caused a decrease clonogenic cell survival and radiosensitization in a human sarcoma cell line with wild-type-p53 gene status. 28 However, the role of survivin-splice variants for therapy response and relationship to hypoxia and radiosensitization has not been investigated. In a previous study on soft tissue sarcoma, patients with survivin-D3 overexpressing tumors had a sevenfold increased risk of tumor-related death in a multivariate Cox's proportional hazards regression model. 37 This implied that not only wild-type survivin, but also the survivin isoforms, for example, survivin-D3
should have an impact on tumor progression and that isoforms could be useful tumor targets.
All siRNA constructs were specific and effective under normoxic as well as hypoxic conditions (Table 1) . However, independent on the siRNA applied, we detected in general the greatest effect on survivin-D3 expression under hypoxia compared to normoxia (Table 1) . It seems that survivin-D3 is critical under hypoxic conditions. Furthermore, we found a markedly reduced (1-to 12-fold) expression of all investigated survivin isoforms, when cells were cultivated under hypoxic conditions compared to normoxic conditions. However, soft tissue sarcoma cell lines show a different kind of behavior after hypoxia than carcinoma cell lines. Yang et al. 38 found survivin expression upregulated via promoter activation under hypoxia in breast cancer and pancreatic cancer cell lines. Additionally, Ueda et al. 45 demonstrated that hypoxia under serum-starved conditions lead to increased survivin expression in human brain microvascular endothelial cells and EGF stimulation in breast cancer cell lines resulted in an upregulation of survivin. 46 This was caused by direct binding and activation of the survivin promoter by the hypoxia-inducible factor (Hif-1a). 46 In this line, knockdown of Hif-1a inhibited the expression of survivin in a pancreatic cancer cell line under hypoxic conditions. 47 In contrast, hypoxia or reoxygenation activated the PI3K/Akt pathway and lead to an upregulation of XIAP but not of survivin in renal epithelial cells. 48 It is well-known that wild-type survivin is essential for cell cycle progression and inhibition of apoptosis. Li 49 proposed that the splice variants survivin-D3 and survivin-2B could form heterodimers with wild-type survivin and may affect the cell cycle progression. Therefore, the survivin-splice variants could be important for tumor progression. Li 29 found that survivin-2B did not colocalize with the mitotic spindle, midbody and chromosomal DNA, whereas survivin-D3 appeared to be translocated to and colocalized with the mitotic spindle in mitotic cells. However, it is not clear if the splice variants have any function during cell cycle. In single transfection experiments, survivin-2B or survivin-D3 was unable to immunoprecipitate endogenous survivin or Aurora B36. In this study, we did not find any effect on cell cycle distribution when survivin-D3 and survivin-2B were knocked down (data not shown). Only the knockdown of wild-type survivin generated polyploid cells. At 24 and 48 h after transfection with SVV 284 siRNA, almost 40 and 50% of the cell line were polyploid, respectively. Figure 6 Cure probabilities after irradiation of megacolonies. The cell lines US 8-93 was irradiated 48 h after small interfering RNA (siRNA) treatment. The data represent the mean value of at least three independent experiments. A significant effect was calculated at a dose of 21 Gy (P ¼ 0.02, two-sided paired Student's t-test).
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Apparently, survivin-D3 and survivin-2B have no essential function during mitosis and cytogenesis. Because of the different subcellular localization of splice variant survivin-D3 (nucleus) and survivin-2B (cytoplasm), it was suggested that they may play different roles in cell cycle and apoptosis. 34, 35 Thus, one mechanism for survivin-2B-related induction of apoptosis is to block mitochondrial-localized survivin delivery into the cytosol by their physical interaction. 10, 29 Therefore, the knockdown of survivin-2B may release wild-type survivin and inhibit apoptosis after a stimulus like irradiation.
We found a reduction of plating efficiency only after knocking down wild-type survivin via siRNA SVV 284 under hypoxic or normoxic conditions, but not after siRNA treatments against survivin-D3 or survivin-2B independent of oxygen concentration (Figure 3) . The combination of siRNA application and irradiation caused no radiosensitization in the cell line US 8-93 in colony formation assay under different oxygen conditions. Similar results were found in a previous study under normoxic conditions. 28 In contrast, we found an increased effectiveness in the megacolony assay ( Figure 6 ). It remains to be demonstrated whether this is due to additive cytotoxicity or due to radiosensitization.
In summary, survivin isoforms mRNA expression was strongly decreased under hypoxic conditions compared to normoxic conditions. Nevertheless, all siRNA constructs effectively knocked down their survivin target mRNA under different oxygen conditions. Treatment with specific siRNA reduced clonogenic survival, especially when the siRNA construct SVV 284 against wild-type survivin was used. In combination with irradiation, we found no radiosensitization after the knockdown of wildtype-survivin, survivin-D3 or survivin-2B under hypoxic or normoxic conditions in the cell line US 8-93 (mt-p53) using colony formation assay, but a radiosensitization effect was detected in the megacolony assay.
Abbreviation siRNA, small interfering RNA.
